212 related articles for article (PubMed ID: 11054645)
1. Estrogen modulates osteoblast proliferation and function regulated by parathyroid hormone in osteoblastic SaOS-2 cells: role of insulin-like growth factor (IGF)-I and IGF-binding protein-5.
Nasu M; Sugimoto T; Kaji H; Chihara K
J Endocrinol; 2000 Nov; 167(2):305-13. PubMed ID: 11054645
[TBL] [Abstract][Full Text] [Related]
2. Regulation of insulin-like growth factor-binding protein-4 protease activity by estrogen and parathyroid hormone in SaOS-2 cells: implications for the pathogenesis of postmenopausal osteoporosis.
Kudo Y; Iwashita M; Itatsu S; Iguchi T; Takeda Y
J Endocrinol; 1996 Aug; 150(2):223-9. PubMed ID: 8869589
[TBL] [Abstract][Full Text] [Related]
3. Effects of estrogen and parathyroid hormone on osteoblastic activity via regulating the binding activity of insulin-like growth factor binding protein-4 in SaOS-2 cells: implications for the pathogenesis of postmenopausal osteoporosis.
Kudo Y; Itatsu S; Iwashita M; Iguchi T; Takeda Y
Biochim Biophys Acta; 1995 Dec; 1245(3):402-6. PubMed ID: 8541319
[TBL] [Abstract][Full Text] [Related]
4. Low-dose parathyroid hormone and estrogen reverse alkaline phosphatase activity suppressed by dexamethasone in mouse osteoblastic cells.
Iu MF; Kaji H; Naito J; Sowa H; Sugimoto T; Chihara K
J Bone Miner Metab; 2005; 23(6):450-5. PubMed ID: 16261451
[TBL] [Abstract][Full Text] [Related]
5. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation.
Yeh LC; Adamo ML; Olson MS; Lee JC
Endocrinology; 1997 Oct; 138(10):4181-90. PubMed ID: 9322928
[TBL] [Abstract][Full Text] [Related]
6. Carboxyl-terminal parathyroid hormone fragments stimulate type-1 procollagen and insulin-like growth factor-binding protein-5 mRNA expression in osteoblastic UMR-106 cells.
Nasu M; Sugimoto T; Kaji H; Kano J; Chihara K
Endocr J; 1998 Apr; 45(2):229-34. PubMed ID: 9700476
[TBL] [Abstract][Full Text] [Related]
7. Positive interaction between 17 beta-Estradiol and parathyroid hormone in normal human osteoblasts cultured long term in the presence of dexamethasone.
Rao LG; Kung Sutherland MS; Muzaffar SA; Wylie JN; McBroom RJ; Murray TM
Osteoporos Int; 1996; 6(2):111-9. PubMed ID: 8704348
[TBL] [Abstract][Full Text] [Related]
8. Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones.
Ernst M; Heath JK; Rodan GA
Endocrinology; 1989 Aug; 125(2):825-33. PubMed ID: 2752978
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells.
Ishizuya T; Yokose S; Hori M; Noda T; Suda T; Yoshiki S; Yamaguchi A
J Clin Invest; 1997 Jun; 99(12):2961-70. PubMed ID: 9185520
[TBL] [Abstract][Full Text] [Related]
10. Genistein modulates the effects of parathyroid hormone in human osteoblastic SaOS-2 cells.
Chen WF; Wong MS
Br J Nutr; 2006 Jun; 95(6):1039-47. PubMed ID: 16768824
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-I inhibits parathyroid hormone-stimulated and enhances prostaglandin E2-stimulated adenosine 3',5'-monophosphate production by human osteoblast-like SaOS-2 cells.
Goad DL; Tashjian AH
Endocrinology; 1993 Oct; 133(4):1585-92. PubMed ID: 8404598
[TBL] [Abstract][Full Text] [Related]
12. Estrogen and parathyroid hormone regulate insulin-like growth factor binding protein-4 in SaOS-2 cells.
Kudo Y; Iwashita M; Iguchi T; Takeda Y; Hizuka N; Takano K; Muraki T
Life Sci; 1997; 61(2):165-70. PubMed ID: 9217275
[TBL] [Abstract][Full Text] [Related]
13. Role of zinc in regulation of protein tyrosine phosphatase activity in osteoblastic MC3T3-E1 cells: zinc modulation of insulin-like growth factor-I's effect.
Yamaguchi M; Fukagawa M
Calcif Tissue Int; 2005 Jan; 76(1):32-8. PubMed ID: 15477998
[TBL] [Abstract][Full Text] [Related]
14. Albumin regulates Runx2 and alpha1 (I) collagen mRNA expression in osteoblastic cells: comparison with insulin-like growth factor-I.
Ishida K; Yamaguchi M
Int J Mol Med; 2005 Oct; 16(4):689-94. PubMed ID: 16142406
[TBL] [Abstract][Full Text] [Related]
15. Studies on the regulation of insulin-like growth factor binding protein 3 secretion in human osteosarcoma cells in vitro.
Nakao Y; Hilliker S; Baylink DJ; Mohan S
J Bone Miner Res; 1994 Jun; 9(6):865-72. PubMed ID: 7521561
[TBL] [Abstract][Full Text] [Related]
16. Estrogen blocks parathyroid hormone (PTH)-stimulated osteoclast-like cell formation by selectively affecting PTH-responsive cyclic adenosine monophosphate pathway.
Kaji H; Sugimoto T; Kanatani M; Nasu M; Chihara K
Endocrinology; 1996 Jun; 137(6):2217-24. PubMed ID: 8641168
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-I mediates osteoclast-like cell formation stimulated by parathyroid hormone.
Kaji H; Sugimoto T; Kanatani M; Nishiyama K; Nasu M; Chihara K
J Cell Physiol; 1997 Jul; 172(1):55-62. PubMed ID: 9207925
[TBL] [Abstract][Full Text] [Related]
18. Potential mechanism of estrogen-mediated decrease in bone formation: estrogen increases production of inhibitory insulin-like growth factor-binding protein-4.
Kassem M; Okazaki R; De León D; Harris SA; Robinson JA; Spelsberg TC; Conover CA; Riggs BL
Proc Assoc Am Physicians; 1996 Mar; 108(2):155-64. PubMed ID: 8705735
[TBL] [Abstract][Full Text] [Related]
19. The expression of insulin-like growth factor-I mRNA and polypeptide in rat osteoblasts with exposure to parathyroid hormone.
Zhang K; Chen J; Wang M; Wang C; Li G; Zheng Z; Zhao R
Chin Med J (Engl); 2003 Dec; 116(12):1916-22. PubMed ID: 14687484
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone.
Bikle DD; Sakata T; Leary C; Elalieh H; Ginzinger D; Rosen CJ; Beamer W; Majumdar S; Halloran BP
J Bone Miner Res; 2002 Sep; 17(9):1570-8. PubMed ID: 12211426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
